Taysha Gene Therapies, Inc. (TSHA) NASDAQ
4.49
-0.12(-2.60%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.49
-0.12(-2.60%)
Currency In USD
| Market Cap | 376.84M |
| Enterprise Value | 300.98M |
| P/E Ratio | -15.87 |
| PEG Ratio | -5.71 |
| Price/Sales Ratio | 147.81 |
| Price/Book Ratio | 7.24 |
| Enterprise/Revenue | 111.64 |
| Enterprise/EBITDA | -7.14 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -15.84 |
| Operating Margin | -16.19 |
| Return On Assets | -0.32 |
| Return On Equity | -0.67 |
| Revenue | 8.33M |
| Revenue/Share | 0.02 |
| Gross Profit | 8.33M |
| EBITDA | -87.95M |
| Net Income | -89.3M |
| Diluted EPS | -0.36 |
| Total Cash | 297.34M |
| Total Cash/Share | 0.84 |
| Total Debt | 69.08M |
| Total Debt/Equity | 0.32 |
| Current Ratio | 10.48 |
| Book Value Per Share | 0.62 |
| 52-Week Change | 161.05 |
| 52-Week High | 6.02 |
| 52-Week Low | 1.05 |
| Moving Average 50 Days | 4.75 |
| Moving Average 200 Days | 3.9 |
| Average Volume | 2.75M |
| Shares Outstanding | 273.92M |
| % Held by Institutions | 76.11 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |